V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 300007466 | 300006754 | 1.6 | 96 | Palliative (P) | 2017-12-20 | 2018-01-18 | Cytarabine Intrathecal (any age) | 2 | N | 300014632 | CISPLATIN |
| 300007467 | 300004215 | 1.73 | 78.2 | Palliative (P) | 2014-12-16 | 2014-12-16 | Cisplatin +Fluorouracil (3 wk) | null | null | 300014663 | PEMBROLIZUMAB |
| 300007468 | 300004216 | 1.61 | 96.1 | Palliative (P) | 2017-02-21 | 2017-03-16 | Gemcitabine + RT pancreas | 02 | Y | 300014664 | CETUXIMAB |
| 300007469 | 300004218 | 1.68 | 63.1 | Palliative (P) | null | 2014-12-06 | Trial Unspecified | 2 | N | 300014670 | TRIAL |
| 300007470 | 300004218 | 1.67 | 117 | Curative (C) | 2016-12-12 | 2017-02-17 | Cetuximab + Radiotherapy Maint | Y | Y | 300014670 | CARBOPLATIN |
| 300007471 | 300004219 | 1.63 | 57 | Adjuvant (A) | 2016-10-14 | 2017-08-13 | Bevacizumab | 02 | N | 300014692 | BEVACIZUMAB |
| 300007472 | 300004221 | 1.69 | null | Curative (C) | 2014-11-19 | 2015-01-08 | CAPECITABINE + RT | null | Y | 300014706 | CARBOPLATIN + RT |
| 300007474 | 300004227 | null | 70.7 | Curative (C) | 2015-07-03 | 2015-07-17 | Carboplatin AUC 2 - 5 | 02 | N | 300014806 | CETUXIMAB + RT |
| 300007475 | 300004228 | 1.57 | 129 | Palliative (P) | 2015-03-30 | 2015-09-08 | Everolimus 10mg | null | N | 300014818 | IRINOTECAN + MDG |
| 300007476 | 300004230 | 1.67 | 44.6 | Palliative (P) | 2016-05-04 | 2016-05-11 | Fluorouricil + Folonic Acid (MdG) | 2 | N | 300014844 | CISPLATIN + FLUOROURACIL |
| 300007477 | 300004233 | 1.68 | 51 | Palliative (P) | 2017-10-27 | 2017-11-26 | Gemcitabine + Capecitabine | 2 | N | 300014859 | TRIAL |
| 300007478 | 300004234 | null | null | Curative (C) | null | 2015-12-12 | Trial Unspecified | N | N | 300014859 | OXALIPLATIN + MDG |
| 300007479 | 300004235 | 1.81 | 84.5 | Curative (C) | 2014-04-02 | 2014-06-12 | FLUOROURACIL + IRINOTECAN + OXALIPLATIN | 02 | N | 300014880 | CVD |
| 300007480 | 300004235 | null | 55 | Curative (C) | 2016-07-01 | 2016-07-29 | Cisplatin | N | Y | 300014880 | CETUXIMAB + RT |
| 300007482 | 300004238 | 1.56 | 54 | Palliative (P) | null | 2014-10-26 | Capecitabine | N | N | 300014892 | CISPLATIN + FLUOROURACIL |
| 300007483 | 300007719 | 1.66 | 63.3 | Curative (C) | 2014-03-12 | 2014-05-04 | CETUXIMAB + RT | 02 | Y | 300014917 | CETUXIMAB + RT |
| 300007484 | 300004243 | 1.84 | null | Palliative (P) | 2014-03-07 | 2014-03-15 | IMATINIB | N | null | 300014927 | CISPLATIN + FLUOROURACIL |
| 300007485 | 300004247 | null | null | Curative (C) | 2015-06-30 | 2015-10-04 | Cetuximab 7 day (>Cycle 2) | null | null | 300014937 | CISPLATIN |
| 300007486 | 300004251 | 1.58 | 51.8 | Curative (C) | 2016-05-31 | 2016-06-02 | Trial Unspecified | 02 | null | 300014948 | IPILIMUMAB |
| 300007487 | 300004253 | 1.65 | 91.5 | Curative (C) | null | 2015-05-20 | CAV | null | null | 300014956 | PACLITAXEL |
| 300007489 | 300004257 | 1.67 | 63.6 | null | null | 2016-07-02 | LUX TRIAL | N | null | 300014985 | CAPECITABINE |
| 300007491 | 300008325 | 1.74 | 91.4 | Palliative (P) | 2015-05-19 | 2015-05-29 | CHOP R - 21 days | N | N | 300015008 | CETUXIMAB |
| 300007492 | 300008349 | 1.49 | null | Curative (C) | 2014-08-10 | 2014-08-10 | Folfirinox | 02 | null | 300015039 | CETUXIMAB |
| 300007493 | 300004263 | 1.66 | 76 | Palliative (P) | 2014-11-17 | 2014-11-17 | FEC 100 + DOCETAXEL | 2 | null | 300015041 | OXALIPLATIN + MDG |
| 300007494 | 300004270 | 1.62 | 103 | Palliative (P) | 2016-09-03 | 2016-10-05 | CARBOPLATIN + PACLITAXEL | 2 | N | 300015077 | CAPECITABINE + GEMCITABINE |
| 300007495 | 300004278 | null | 57.95 | Curative (C) | 2016-11-30 | 2016-12-04 | Cisplatin 7 day | 2 | null | 300015108 | TRIAL |
| 300007497 | 300004283 | 1.75 | 76.1 | Palliative (P) | 2013-10-21 | 2013-10-21 | Trial Unspecified | 02 | N | 300015127 | OXALIPLATIN + MDG |
| 300007498 | 300004283 | 1.63 | 77.3 | Curative (C) | 2015-07-19 | 2016-07-25 | CARBOPLATIN + RT | 02 | N | 300015127 | CAPECITABINE |
| 300007499 | 300004283 | 1.81 | null | null | 2013-11-08 | 2013-11-29 | Oxaliplatin + Modified de Gramont | null | null | 300015127 | PEMBROLIZUMAB |
| 300007500 | 300004287 | 1.55 | 90 | Disease modification (D) | 2014-11-25 | 2014-11-25 | FLUOROURACIL + OXALIPLATIN | 02 | N | 300015157 | COMPARE TRIAL |
| 300007501 | 300004290 | 1.8 | 89.7 | Palliative (P) | 2016-09-11 | 2016-10-31 | Bortezomib +/- Dexamethasone | 02 | N | 300015159 | CARBOPLATIN + ETOPOSIDE |
| 300007502 | 300004292 | 1.57 | null | Palliative (P) | 2017-09-25 | 2017-09-28 | KESTREL Trial | 02 | N | 300015176 | CAPECITABINE |
| 300007503 | 300004292 | 1.71 | 107 | null | 2017-12-26 | 2018-01-06 | Cetuximab + Radiotherapy Load | N | Y | 300015176 | CISPLATIN |
| 300007505 | 300004295 | 1.65 | 98.8 | Palliative (P) | 2017-09-04 | 2017-09-08 | Cetuximab + Radiotherapy Maint | N | Y | 300015203 | CAPECITABINE |
| 300007506 | 300004299 | 1.53 | 57.1 | Palliative (P) | 2018-12-11 | 2018-12-11 | Trial Unspecified | N | null | 300015210 | CISPLATIN |
| 300007507 | 300004305 | 1.7 | 52.8 | Palliative (P) | 2014-08-10 | 2014-12-22 | Bevacizumab | N | N | 300015251 | CISPLATIN + FLUOROURACIL |
| 300007508 | 300004307 | 1.7 | 69.8 | Palliative (P) | 2016-07-16 | 2016-08-14 | Gemcitabine + Capecitabine | N | N | 300015255 | BEVACIZUMAB |
| 300007509 | 300004309 | 1.85 | 70.4 | Palliative (P) | 2015-01-31 | 2015-04-27 | Capecitabine + Oxaliplatin 21day | N | N | 300015276 | CARBOPLATIN + PACLITAXEL |
| 300007510 | 300004311 | 1.75 | 87 | Palliative (P) | 2015-07-26 | 2015-08-17 | Trial Unspecified | Y | N | 300015282 | LOMUSTINE |
| 300007511 | 300004313 | null | null | Palliative (P) | 2017-01-22 | 2017-04-04 | Capecitabine | N | null | 300015288 | TRIAL |
| 300007512 | 300004316 | 1.71 | 64.6 | Palliative (P) | 2014-07-05 | 2014-07-11 | Bortezomib + Cyclophos + Dex | 2 | N | 300015302 | CAPECITABINE + IRINOTECAN |
| 300007513 | 300004317 | 1.58 | 67 | Palliative (P) | 2019-01-06 | 2019-01-06 | CETUXIMAB | N | N | 300015303 | CAPECITABINE + OXALIPLATIN |
| 300007514 | 300004321 | 1.65 | 80.4 | Palliative (P) | 2012-10-03 | 2013-07-28 | CAPECITABINE + OXALIPLATIN | N | N | 300015347 | FLUOROURACIL + IRINOTECAN + OXALIPLATIN |
| 300007516 | 300004329 | 1.63 | 72.4 | Palliative (P) | null | 2016-12-21 | Capecitabine | N | N | 300015419 | CARBOPLATIN |
| 300007517 | 300004331 | 1.57 | 65 | Disease modification (D) | 2015-08-08 | 2015-11-06 | Capecitabine | N | N | 300015434 | TRIAL |
| 300007519 | 300006800 | 1.78 | 53.8 | Palliative (P) | 2014-01-18 | 2014-01-18 | Trial Unspecified | 02 | N | 300015466 | FLUOROURACIL + IRINOTECAN + OXALIPLATIN |
| 300007520 | 300004336 | 1.55 | 53.5 | Palliative (P) | null | 2018-06-12 | Oxaliplatin + Modified de Gramont | 02 | N | 300015484 | OXALIPLATIN + MDG |
| 300007521 | 300004337 | 1.66 | 112 | Palliative (P) | 2013-12-04 | 2014-02-10 | Carboplatin + Cetux + FU (>Cycle 2) | 02 | Y | 300015484 | CETUXIMAB + RT |
| 300007522 | 300004341 | 1.58 | 0 | Disease modification (D) | 2014-08-02 | 2014-08-03 | GemCarbo Days 1+8 | 02 | N | 300015502 | PACLITAXEL |
| 300007523 | 300004345 | 1.66 | 120 | Palliative (P) | null | 2015-12-15 | Irinotecan | 02 | N | 300015534 | TRIAL |